The Formulation Development Outsourcing Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Service (Preformulation, Formulation Development), By Formulation (Oral, Injectable, Topical, Others), By Therapeutic Area (Oncology, Infectious disease, Neurology, Hematology, Respiratory, Cardiovascular, Dermatology, Others).
The formulation development outsourcing market in 2024 serves the demand for contract research and development (R&D) services and pharmaceutical formulation expertise used by biopharmaceutical companies, drug developers, and contract development and manufacturing organizations (CDMOs) to accelerate drug discovery, formulation optimization, and dosage form development for new chemical entities (NCEs), generic drugs, and specialty pharmaceuticals. Formulation development outsourcing involves partnering with specialized contract research organizations (CROs) and formulation service providers to access expertise in pharmaceutical formulation sciences, preformulation studies, formulation design, process optimization, and analytical testing, enabling efficient and cost-effective drug development from early-stage formulation screening to late-stage formulation optimization and scale-up manufacturing. Market dynamics are driven by factors such as the increasing complexity of drug molecules and delivery systems, the growing demand for innovative drug formulations and patient-centric dosage forms, and the need for flexible and scalable R&D solutions to address drug development challenges and shorten time-to-market. Collaboration between formulation development CROs, pharmaceutical companies, and regulatory agencies drives innovation and market expansion in formulation development outsourcing, supporting more efficient drug development pipelines, regulatory submissions, and commercialization strategies for new pharmaceutical products and drug delivery technologies.
A notable trend in the Formulation Development Outsourcing market is the growing reliance on outsourcing for formulation development services by pharmaceutical and biotechnology companies. This trend is driven by several factors, including the need to reduce costs, access specialized expertise, and accelerate product development timelines. Outsourcing formulation development allows companies to leverage the capabilities of contract development and manufacturing organizations (CDMOs) or contract research organizations (CROs) with extensive experience and infrastructure in formulation design, optimization, and scale-up. Additionally, outsourcing enables companies to focus on their core competencies while gaining access to external resources for efficient and cost-effective formulation development.
A key driver in the Formulation Development Outsourcing market is the increasing complexity in drug formulation and the stringent regulatory requirements governing pharmaceutical product development. The development of novel drug candidates with complex physicochemical properties, such as poor solubility, instability, and targeted delivery requirements, presents significant challenges for formulation scientists. Moreover, regulatory agencies impose rigorous standards for drug product quality, safety, and efficacy, necessitating thorough formulation optimization and robust manufacturing processes. As a result, pharmaceutical companies seek outsourcing partners with expertise in overcoming formulation challenges and ensuring compliance with regulatory guidelines, driving the demand for formulation development outsourcing services.
An opportunity for market growth in the Formulation Development Outsourcing market lies in the provision of specialized formulation services tailored for biologics and advanced therapies. With the increasing focus on biopharmaceuticals, including monoclonal antibodies, gene therapies, and cell-based therapies, there is a growing demand for formulation expertise specific to these complex modalities. Biologics often present unique formulation challenges related to stability, delivery, and compatibility with delivery devices. CDMOs/CROs that offer specialized capabilities in biologics formulation development, including formulation optimization for protein-based therapeutics, lyophilization, and formulation characterization, can capitalize on the growing market demand for biopharmaceutical development outsourcing. Additionally, catering to the emerging field of advanced therapies, such as gene editing and cell therapy, presents an opportunity for formulation development service providers to expand their service offerings and address the evolving needs of the pharmaceutical industry.
By Service
By Formulation
By Therapeutic Area
Geographical Analysis
*- List Not Exhaustive
1. Executive Summary
1.1 Introduction to Formulation Development Outsourcing Markets
1.2 Formulation Development Outsourcing Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Formulation Development Outsourcing Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Formulation Development Outsourcing Market Trends
3.2 Key Formulation Development Outsourcing Market Growth Drivers
3.3 Key Formulation Development Outsourcing Market Growth Restraints
4 Formulation Development Outsourcing Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Formulation Development Outsourcing Market Segmentation- Outlook by Type
5.1 Preformulation Market Outlook to 2030
5.2 Formulation Development Market Outlook to 2030
6. Formulation Development Outsourcing Market Segmentation- Outlook by Formulation
6.1 Oral Market Outlook to 2030
6.2 Injectable Market Outlook to 2030
6.3 Topical Market Outlook to 2030
6.4 Others Market Outlook to 2030
7. Formulation Development Outsourcing Market Segmentation- Outlook by Therapeutic Area
7.1 Oncology Market Outlook to 2030
7.2 Infectious Diseases Market Outlook to 2030
7.3 Neurology Market Outlook to 2030
7.4 Hematology Market Outlook to 2030
7.5 Respiratory Market Outlook to 2030
7.6 Cardiovascular Market Outlook to 2030
7.7 Dermatology Market Outlook to 2030
7.8 Others Market Outlook to 2030
8. North America Formulation Development Outsourcing Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Formulation Development Outsourcing Market Growth Opportunities
8.3 North America Formulation Development Outsourcing Market Outlook by Application
8.4 North America Formulation Development Outsourcing Market Outlook by Type
8.5 North America Formulation Development Outsourcing Market Outlook by Country
8.6 United States Formulation Development Outsourcing Market Outlook
8.7 Canada Formulation Development Outsourcing Market Outlook
8.8 Mexico Formulation Development Outsourcing Market Outlook
9. Europe Formulation Development Outsourcing Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Formulation Development Outsourcing Market Outlook by Application
9.3 Europe Formulation Development Outsourcing Market Outlook by Type
9.4 Europe Formulation Development Outsourcing Market Outlook by Country
9.5 Germany Formulation Development Outsourcing Market Outlook
9.6 France Formulation Development Outsourcing Market Outlook
9.7 United Kingdom Formulation Development Outsourcing Market Outlook
9.8 Spain Formulation Development Outsourcing Market Outlook
9.9 Italy Formulation Development Outsourcing Market Outlook
9.10 Other Europe Formulation Development Outsourcing Market Outlook
10. Asia Pacific Formulation Development Outsourcing Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Formulation Development Outsourcing Market Outlook by Application
10.3 Asia Pacific Formulation Development Outsourcing Market Outlook by Type
10.4 Asia Pacific Formulation Development Outsourcing Market Outlook by Country
10.5 China Formulation Development Outsourcing Market Outlook
10.6 Japan Formulation Development Outsourcing Market Outlook
10.7 India Formulation Development Outsourcing Market Outlook
10.8 Other Asia Pacific Formulation Development Outsourcing Market Outlook
11. Latin America Formulation Development Outsourcing Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 Latin America Formulation Development Outsourcing Market Outlook by Application
11.3 Latin America Formulation Development Outsourcing Market Outlook by Type
11.4 Latin America Formulation Development Outsourcing Market Outlook by Country
11.5 Brazil Formulation Development Outsourcing Market Outlook
11.6 Argentina Formulation Development Outsourcing Market Outlook
11.7 Other Latin America Formulation Development Outsourcing Market Outlook
12. Middle East and Africa Formulation Development Outsourcing Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and AfricaFormulation Development Outsourcing Market Outlook by Application
12.3 Middle East and AfricaFormulation Development Outsourcing Market Outlook by Type
12.4 Middle East and AfricaFormulation Development Outsourcing Market Outlook by Country
12.5 Saudi Arabia Formulation Development Outsourcing Market Outlook
12.6 UAE Formulation Development Outsourcing Market Outlook
12.7 South Africa Formulation Development Outsourcing Market Outlook
12.8 Other Middle East and Africa Formulation Development Outsourcing Market Outlook
13 Profiles of major Formulation Development Outsourcing Companies
SGS SA
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Intertek Group plc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Recipharm AB
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Lonza Group
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Charles River Laboratories Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Eurofins Scientific SE
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Element Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
LabCorp Holdings
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Thermo Fisher Scientific Corp
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Catalent Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
By Service
By Formulation
By Therapeutic Area
Geographical Analysis